(Q49080582)

18 February 2018

title

Improved design and intranasal delivery of an M2e-based human influenza A vaccine. (English)

1 reference

18 February 2018

1 reference

1 reference

7

Nils Lycke

1 reference

18 February 2018

Xavier Saelens

9

object named as

Xavier Saelens

1 reference

18 February 2018

Walter Fiers

2

object named as

Walter Fiers

1 reference

18 February 2018

author name string

Marina De Filette

1

1 reference

18 February 2018

Wouter Martens

3

1 reference

18 February 2018

Ashley Birkett

4

1 reference

18 February 2018

Anna Ramne

5

1 reference

18 February 2018

Björn Löwenadler

6

1 reference

18 February 2018

Willy Min Jou

8

1 reference

18 February 2018

language of work or name

English

0 references

publication date

12 June 2006

1 reference

18 February 2018

published in

Vaccine

1 reference

18 February 2018

volume

24

1 reference

18 February 2018

issue

44-46

1 reference

18 February 2018

page(s)

6597-6601

1 reference

18 February 2018

Influenza: old and new threats

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.082

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.082

Mortality associated with influenza and respiratory syncytial virus in the United States

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.082

Genesis of a highly pathogenic and potentially pandemic H5N1 influenza virus in eastern Asia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.082

Influenza vaccination coverage rates in five European countries-a population-based cross-sectional analysis of two consecutive influenza seasons

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.082

The universal influenza vaccine M2e-HBc administered intranasally in combination with the adjuvant CTA1-DD provides complete protection.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.082

Universal influenza A vaccine: optimization of M2-based constructs.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.082

A universal influenza A vaccine based on the extracellular domain of the M2 protein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.082

Nasal-associated lymphoid tissue is a mucosal inductive site for virus-specific humoral and cellular immune responses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.082

The CTA1-DD vaccine adjuvant binds to human B cells and potentiates their T cell stimulating ability

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.082

The cholera toxin-derived CTA1-DD vaccine adjuvant administered intranasally does not cause inflammation or accumulate in the nervous tissues

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.082

Antibody response to the M2 protein of influenza A virus expressed in insect cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.082

Influenza virus M2 protein is an integral membrane protein expressed on the infected-cell surface

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.082

Large-scale sequencing of human influenza reveals the dynamic nature of viral genome evolution

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.082

Synthesis of hepatitis B virus e antigen in E. coli

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.082

Priming Th1 immunity to viral core particles is facilitated by trace amounts of RNA bound to its arginine-rich domain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.082

Chimeric hepatitis B core antigen particles containing B- and Th-epitopes of human papillomavirus type 16 E7 protein induce specific antibody and T-helper responses in immunised mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.082

High epitope density in a single recombinant protein molecule of the extracellular domain of influenza A virus M2 protein significantly enhances protective immunity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.082

Induction of influenza type A virus-specific resistance by immunization of mice with a synthetic multiple antigenic peptide vaccine that contains ectodomains of matrix protein 2.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.082

Human influenza virus A/HongKong/156/97 (H5N1) infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.082

Influenza: lessons from past pandemics, warnings from current incidents.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.082

H5N1 influenza: a protean pandemic threat

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.082

Preclinical study of influenza virus A M2 peptide conjugate vaccines in mice, ferrets, and rhesus monkeys

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.082

Modified M2 proteins produce heterotypic immunity against influenza A virus.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.082

Influenza A vaccine based on the extracellular domain of M2: weak protection mediated via antibody-dependent NK cell activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.082

Vaccination of pigs with a DNA construct expressing an influenza virus M2-nucleoprotein fusion protein exacerbates disease after challenge with influenza A virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.082

Hepatitis B virus nucleocapsid assembly: primary structure requirements in the core protein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.082

7 January 2021

inferred from DOI database lookup

Identifiers

DOI

10.1016/J.VACCINE.2006.05.082

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/jx3is5txarhzhogofa54rppv3a

30 July 2022

mapped directly with Wikidata item

Fatcat ID

release_jx3is5txarhzhogofa54rppv3a

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/jx3is5txarhzhogofa54rppv3a

30 July 2022

mapped directly with Wikidata item

https://api.fatcat.wiki/v0/release/jx3is5txarhzhogofa54rppv3a

1 reference

30 July 2022